StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
PAP.AT$3.40+0.59%
Fair $3.40+0.0%

PAP.AT

Papoutsanis S.A.

Consumer Defensive / Household & Personal ProductsAthens

$3.40

+0.02 (+0.59%)

Fairly Valued+0.0%Fair Value $3.40Fund rank 25/100 · Data gapFallback financials|
SA 48/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $744627.00 · quality 40.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 14/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

48/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · PAP.ATLocal privado en este navegador · Papoutsanis S.A.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$92M

P/E

14.8x

↓

EV/EBITDA

10.1x

↑

ROE

17.3%

↑

Gross Margin

36.8%

↑

Debt/Equity

0.64

↑
52-Week Range$3
$3$4

TradingView lightweight chart

PAP.AT price, volumen y niveles de valoración

Último $3.400Periodo -99.3%
Fair value: $3.400

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+4.1%

FCF CAGR

—

FCF margin

7.2%

FCF / Net income

0.93x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $79.9M · net income $6.2M · FCF $5.8M

2022-FY → 2025-FY

Gross margin

36.8%+12.3% pts

Operating margin

31.7%+11.1% pts

Net margin

7.8%+3.5% pts

FCF margin

7.2%+10.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$79.9M$79.9M$66.2M$62.3M$70.7M
Net Income$6.2M$6.2M$5.3M$4.1M$3.0M
EBITDA$10.8M$10.8M$10.1M$8.8M$6.6M
EPS0.230.230.190.150.11
Gross Margin36.8%36.8%37.3%34.1%24.4%
Operating Margin31.7%31.7%31.5%28.1%20.6%
Net Margin7.8%7.8%8.0%6.6%4.2%
Balance Sheet
Debt/Equity0.640.640.860.811.11
Current Ratio1.171.17———
Cash Flow
Free Cash Flow$5.8M$5.8M$-1.7M$744627.00$-2.4M
Returns
ROE17.3%17.3%16.7%13.7%11.1%
Valuation
P/E14.7814.7813.0115.6021.14
EV/EBITDA10.1410.149.029.3012.37
P/B2.542.542.172.142.35
Growth & Yield
Revenue Growth20.6%20.6%6.3%-12.0%—
EPS Growth19.5%19.5%29.5%36.7%—
Dividend Yield3.0%3.0%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

9.2%

razonable

EPS terminal req.

$0.30

Spread vs growth

10.4%

5Y implied EPS CAGR

9.5%

razonable

EPS terminal req.

$0.37

Spread vs growth

10.0%

10Y implied EPS CAGR

9.7%

razonable

EPS terminal req.

$0.59

Spread vs growth

9.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +28.3%

Total return

+28.3%

Start / end P/E

14.0x → 14.7x

EPS bridge

0.19 → 0.23

Residual

+0.9%

EPS growth+19.5%
Multiple rerating+4.8%
Dividend+3.0%
Residual / FX / buybacks / cross-term+0.9%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.